CA2523739A1 - Heterocyclic compounds for use in the treatment of viral infections - Google Patents

Heterocyclic compounds for use in the treatment of viral infections Download PDF

Info

Publication number
CA2523739A1
CA2523739A1 CA002523739A CA2523739A CA2523739A1 CA 2523739 A1 CA2523739 A1 CA 2523739A1 CA 002523739 A CA002523739 A CA 002523739A CA 2523739 A CA2523739 A CA 2523739A CA 2523739 A1 CA2523739 A1 CA 2523739A1
Authority
CA
Canada
Prior art keywords
furo
decyl
alkyl
pyrimidin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002523739A
Other languages
English (en)
French (fr)
Inventor
Christopher Mcguigan
Jan Balzarini
Erik De Clercq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rega Foundation
University College Cardiff Consultants Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2523739A1 publication Critical patent/CA2523739A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002523739A 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections Abandoned CA2523739A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0309506 2003-04-25
GB0309506.4 2003-04-25
PCT/GB2004/001687 WO2004096813A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Publications (1)

Publication Number Publication Date
CA2523739A1 true CA2523739A1 (en) 2004-11-11

Family

ID=33397005

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002523739A Abandoned CA2523739A1 (en) 2003-04-25 2004-04-21 Heterocyclic compounds for use in the treatment of viral infections

Country Status (7)

Country Link
US (1) US20070191373A1 (https=)
EP (1) EP1622913A1 (https=)
JP (1) JP2006524672A (https=)
AU (1) AU2004234110A1 (https=)
CA (1) CA2523739A1 (https=)
MX (1) MXPA05010802A (https=)
WO (1) WO2004096813A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083923A (en) * 1997-10-31 2000-07-04 Isis Pharmaceuticals Inc. Liposomal oligonucleotide compositions for modulating RAS gene expression
EP2318415B1 (en) 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
AR079981A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido
CN102834400B (zh) * 2010-01-14 2015-06-10 赛诺菲 2,5-取代的*唑并嘧啶衍生物
CN102791717B (zh) * 2010-01-14 2016-03-30 赛诺菲 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物
AR082453A1 (es) 2010-04-21 2012-12-12 Novartis Ag Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
GB201111779D0 (en) 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
WO2014140077A1 (en) 2013-03-14 2014-09-18 Glaxosmithkline Intellectual Property (No.2) Limited Furopyridines as bromodomain inhibitors
BR112022025710A2 (pt) 2020-06-19 2023-03-07 Bayer Ag 1,3,4-oxadiazol pirimidinas e 1,3,4-oxadiazol piridinas como fungicidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444148A1 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents

Also Published As

Publication number Publication date
EP1622913A1 (en) 2006-02-08
WO2004096813A1 (en) 2004-11-11
JP2006524672A (ja) 2006-11-02
MXPA05010802A (es) 2005-12-14
AU2004234110A1 (en) 2004-11-11
US20070191373A1 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
AU737902B2 (en) Anti-viral pyrimidine nucleoside analogues
Lin et al. Synthesis and antiviral activity of various 3'-azido analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV)
DE69021242T2 (de) Antivirale Verbindungen.
CA2119351C (en) Phosphoramidate analogs of 5-fluoro-2'-deoxyuridine
AU780879B2 (en) Anti-viral pyrimidine nucleoside analogues
HU201773B (en) Process for producing rebeccamycin analogs and pharmaceutical compositions comprising such active ingredient
WO2001083501A1 (en) Anti-viral pyrimidine nucleoside analogues
JP2003238586A (ja) 立体規則性の高いジヌクレオシドホスホロチオエートの製造法
CA2523739A1 (en) Heterocyclic compounds for use in the treatment of viral infections
CH676712A5 (https=)
AU617724B2 (en) 9-(2-(Phosphonomethoxy)Ethoxy) Purine derivatives, intermediates and use as pharmaceuticals
EP0329108A2 (en) Epipodophyllotoxin glucoside lactam derivatives
KR900006234B1 (ko) 신규의 3', 4'-디니트로겐 치환 에피포도필로톡신 배당체의 유도체
Hah et al. The stereoselective synthesis of cyclopropylphosphonate analogs of nucleotides
US5126347A (en) Isomeric dideoxynuclesides
IE904162A1 (en) Alkoxymethylidene epipodophyllotoxin glucosides
EP0110575A1 (en) 1-Aroyl-5-oxo-2-pyrrolidinepropanoic acids and related esters
US5420117A (en) 5-substituted uridine derivatives
MXPA99009965A (en) Anti-viral pyrimidine nucleoside analogues
US5585364A (en) Antiviral compounds
EP2821412A1 (en) Organometallic 2-cyano-2-aminobenzoate-propyl derivates and their use as anthelmintics
CN113880883A (zh) 核苷类磷酸酯前药的制备方法
CA2923370A1 (en) Organometallic compounds for use as anthelmintics
Wittmann et al. Supplemental Data Structures of the Human Orotidine-5′-Monophosphate Decarboxylase Support a Covalent Mechanism and Provide a Framework for Drug Design
KR19980049575A (ko) 항암 효과가 있는 새로운 피롤리진 유도체, 그의 염 및 그들의 용매 화합물 그리고 그들의 제조방법

Legal Events

Date Code Title Description
FZDE Discontinued